LONA
Leonabio Inc
NASDAQ · Pharmaceuticals
$4.58
-0.21 (-4.38%)
Open$4.85
Previous Close$4.79
Day High$4.92
Day Low$4.58
52W High$39.83
52W Low$26.81
Volume—
Avg Volume798.0K
Market Cap42.76M
P/E Ratio24.15
EPS$1.44
SectorPharmaceuticals
Analyst Ratings
Strong Sell
7 analysts
Price Target
+778.2% upside
Current
$4.58
$4.58
Target
$40.22
$40.22
$30.63
$40.22 avg
$46.08
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.05M | 8.81M | 7.55M |
| Net Income | 1.50M | 1.95M | 1.65M |
| Profit Margin | 16.6% | 22.2% | 21.9% |
| EBITDA | 2.36M | 2.47M | 1.95M |
| Free Cash Flow | 1.28M | 1.29M | 705.7K |
| Rev Growth | -8.9% | +8.5% | +16.9% |
| Debt/Equity | 0.33 | 0.32 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |